Clinical Trial Update: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating short-course glucocorticoids plus rituximab for ANCA-associated vasculitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)
• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Phase 4 | Status: COMPLETED | Results posted: 2018-08-17